Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias

被引：104

作者：

Carta, Manolo ^{[1
,2
]}

Carlsson, Thomas ^{[1
,2
]}

Munoz, Ana ^{[1
]}

Kirik, Deniz ^{[2
]}

Bjorklund, Anders ^{[1
]}

机构：

[1] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Neurobiol Unit, Lund, Sweden

[2] Lund Univ, Dept Expt Med Sci, Sect Neurosci, Brain Repair & Imaging Neural Syst Unit, Lund, Sweden

来源：

SEROTONIN-DOPAMINE INTERACTION: EXPERIMENTAL EVIDENCE AND THERAPEUTIC RELEVANCE | 2008年 / 172卷

关键词：

L-DOPA; dopamine; serotonin; dyskinesia; 5-HT agonists; serotonin autoreceptors;

D O I：

10.1016/S0079-6123(08)00922-9

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Appearance of dyskinesia is a common problem of long-term Levodopa (L-DOPA) treatment in Parkinson's disease (PD) patients and represents a major limitation for the pharmacological management of the motor symptoms in the advanced stages of disease. An increasing body of evidence points to dopamine released as a false neurotransmitter from the striatal serotonin terminals as the main pre-synaptic determinant of L-DOPA-induced dyskinesia. Here we review the animal experimental and human clinical data in support of this view, which point to the serotonin system as a promising target for anti-dyskinetic therapy in PD patients under L-DOPA medication.

引用

收藏

页码：465 / 478

页数：14

相关论文

共 87 条

[1] The role of 5-HT1B receptors in the regulation of serotonin cell firing and release in the rat brain [J].

Adell, A ;

Celada, P ;

Artigas, F .

JOURNAL OF NEUROCHEMISTRY, 2001, 79 (01) :172-182

[2] Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature [J].

Ahlskog, JE ;

Muenter, MD .

MOVEMENT DISORDERS, 2001, 16 (03) :448-458

[3] Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease [J].

Andersson, M ;

Hilbertson, A ;

Cenci, MA .

NEUROBIOLOGY OF DISEASE, 1999, 6 (06) :461-474

[4]

[Anonymous], NEUROBIOL DIS

[5] Effects of sarizotan on the corticostriatal glutamate pathways [J].

Antonelli, T ;

Fuxe, K ;

Tomasini, MC ;

Bartoszyk, GD ;

Seyfried, CA ;

Tanganelli, S ;

Ferraro, L .

SYNAPSE, 2005, 58 (03) :193-199

[6] Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study [J].

Arai, R ;

Karasawa, N ;

Nagatsu, I .

BRAIN RESEARCH, 1996, 706 (01) :177-179

[7] IMMUNOHISTOCHEMICAL EVIDENCE THAT CENTRAL SEROTONIN NEURONS PRODUCE DOPAMINE FROM EXOGENOUS L-DOPA IN THE RAT, WITH REFERENCE TO THE INVOLVEMENT OF AROMATIC L-AMINO-ACID DECARBOXYLASE [J].

ARAI, R ;

KARASAWA, N ;

GEFFARD, M ;

NAGATSU, T ;

NAGATSU, I .

BRAIN RESEARCH, 1994, 667 (02) :295-299

[8] L-DOPA IS CONVERTED TO DOPAMINE IN SEROTONERGIC FIBERS OF THE STRIATUM OF THE RAT - A DOUBLE-LABELING IMMUNOFLUORESCENCE STUDY [J].

ARAI, R ;

KARASAWA, N ;

GEFFARD, M ;

NAGATSU, I .

NEUROSCIENCE LETTERS, 1995, 195 (03) :195-198

[9] Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia [J].

Aubert, I ;

Guigoni, C ;

Håkansson, K ;

Li, Q ;

Dovero, S ;

Barthe, N ;

Bioulac, BH ;

Gross, CE ;

Fisone, G ;

Bloch, B ;

Bezard, E .

ANNALS OF NEUROLOGY, 2005, 57 (01) :17-26

[10] Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease [J].

Bara-Jimenez, W ;

Bibbiani, F ;

Morris, MJ ;

Dimitrova, T ;

Sherzai, A ;

Mouradian, MM ;

Chase, TN .

MOVEMENT DISORDERS, 2005, 20 (08) :932-936

← 1 2 3 4 5 6 7 8 9 →